Article Information
History
- March 25, 2016.
Article Versions
- Version 1 (March 24, 2016 - 13:20).
- You are currently viewing Version 2 of this article (March 25, 2016 - 09:01).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Rémy Brossel1,
- Alexandre Yahi2,
- Stéphane David3,
- Laura Moreno Velasquez4 and
- Jean-Marc Guinebretière5
- 1Cell Constraint & Cancer Inc (CC&C), Le mas l’Hermite, 331 chemin de la Poterie, 13280 Raphèle-les-Arles, France;
- 2Institut Curie, 35 rue Dailly, 92210 Saint-Cloud, France. School of Electrical and Computer Engineering, College of Engineering, Georgia Institute of Technology, 777 Atlantic Dr NW, Atlanta, GA 30332-0250, USA; Supelec, 3 rue Joliot-Curie, Gif sur Yvette 91192 France;
- 3Altran Research, 2 rue Paul Dautier, 78140 Vélizy-Villacoublay, France;
- 4Institut Curie, 35 rue Dailly, 92210 Saint-Cloud, France. Physiologie Intégrée du Système d’éveil, Centre de Recherches en Neurosciences de Lyon (CNRL), Inserm U1028, CNRS UMR5292, Faculté de médecine, 8 Avenue Rockefeller, 69373 Lyon Cedex 08, France;
- 5Pathology Department, Hôpital René-Huguenin Institut Curie, 35 rue Dailly, 92210 Saint-Cloud, France.
- *Corresponding author: Rémy Brossel, MD, Oncologist, CSO of CC&C, Le mas l’Hermite, 331, chemin de la Poterie, 13280 Raphèle-les-Arles, France; Phone: +336 738 769 87; Fax: +334 904 954 13; email: brossel.remy{at}gmail.com